Vascular endothelial growth factor a modified mRNA engineered cellular electrospun membrane complexes promotes mouse skin wound repair
Materials Today Bio · 2023-10 · 22 · 100776
DOI: 10.1016/j.mtbio.2023.100776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2023-10. Verfasst von Xuefeng Ai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiothoracic Surgery, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 2001…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shanghai Municipality, Shanghai Science and Technology Development Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Artificial skin substitutes are one of the most promising areas of wound healing research; however, graft survival largely depends on how the treatment is performed. Early angiogenesis is essential for wound healing and graft survival and vascular endothelial growth factor A (VEGFA) is an important cytokine that stimulates angiogenesis. Here, we first investigated the effects of different ratios of collagen (BC) and gelatin blended with poly (l-lactide-co-caprolactone) (PLCL) on nanofibrous membranes. The Young's modulus and cell proliferation were significantly higher in the 50% BC group than that in all other groups. Then, cellular electrospun membrane complexes (CEMC) were successfully constructed from nanoscaffolds and fibroblasts extracted from human foreskin and engineered with controlled autocrine VEGFA by transfecting VEGFA modified mRNA (modRNA). Engineered CEMC significantly promoted wound healing in vivo and contributed to stable vascular network formation in the grafted area, thereby increasing the survival rate of the engineered skin. This study provides a potential solution for wound healing while establishing the value of different RNA modification methods for various engineered skins in the future, thereby advancing engineered skin development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cardiothoracic Surgery, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
- Institute of Pediatric Translational Medicine, Shanghai Institute for Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, China.
- Shanghai Key Laboratory of Tissue Engineering, Shanghai 9th People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200011, China.
Förderung
- Natural Science Foundation of Shanghai Municipality
- Shanghai Science and Technology Development Foundation
- National Natural Science Foundation of China
Zitieren
APA
Ai, X., Luo, R., Wang, H., Yan, B., Li, K., Yu, X., Dong, W., Tan, Y., Liu, M., Chen, Y., Lu, T., Wang, X., Wang, W., & Fu, W. (2023). Vascular endothelial growth factor a modified mRNA engineered cellular electrospun membrane complexes promotes mouse skin wound repair. Materials Today Bio, 22, 100776. https://doi.org/10.1016/j.mtbio.2023.100776
Vancouver
Ai X, Luo R, Wang H, Yan B, Li K, Yu X, et al. Vascular endothelial growth factor a modified mRNA engineered cellular electrospun membrane complexes promotes mouse skin wound repair. Materials Today Bio. 2023;22:100776. doi:10.1016/j.mtbio.2023.100776
BibTeX
@article{Ai2023,
author = {Ai, Xuefeng and Luo, Runjiao and Wang, Huijing and Yan, Bingqian and Li, Kaixiang and Yu, Xindi and Dong, Wei and Tan, Yao and Liu, Minglu and Chen, Ying and Lu, Tingting and Wang, Xiangying and Wang, Wei and Fu, Wei},
title = {Vascular endothelial growth factor a modified mRNA engineered cellular electrospun membrane complexes promotes mouse skin wound repair},
journal = {Materials Today Bio},
year = {2023},
volume = {22},
pages = {100776},
doi = {10.1016/j.mtbio.2023.100776}
}
EUVIMED